Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on Feb. 29, 2024 that were previously approved by the Compensation Committee of its...

Related Keywords

,Facebook ,Nasdaq ,Linkedin ,Compensation Committee ,Sarepta Therapeutics Inc ,Twitter ,Instagram ,Sarepta Therapeutics ,Commencement Incentive Plan ,Nasdaq Listing Rule ,Grant Date ,Precision Genetic Medicine Engine ,For Investor ,Markets ,